News

MitoSense Sponsors Countdown For A Cure and Celebrates CFAC’s Annual Event

February 6, 2026 – Plymouth, MA – MitoSense, Inc., a biotechnology company advancing mitochondrial-based therapies, is proud to announce its sponsorship of Countdown For A Cure (CFAC) and to congratulate the organization on the success of its annual signature event. Countdown For A Cure is a nonprofit organization dedicated to advancing mitochondrial research and increasing awareness of the critical role cellular energy plays in health, disease prevention, and longevity. Thro

Feb 6

MitoSense to Attend MHSRS, August 4 -7, 2025

MitoSense, Inc. is proud to announce its participation in the 2025 Military Health System Research Symposium (MHSRS), taking place August...

Jul 29, 2025

MitoSense's Collaboration with the VA and WRAIR Highlighted in House Hearing with HHS Secretary RFK, Jr.

Earlier this week, the U.S. House of Representatives Energy and Commerce Health Subcommittee held a hearing with Department of Health and...

Jun 26, 2025

MitoSense’s MOT™ Technology Featured In Newsmax Article Highlighting Secretary Kennedy’s Vision To Tackle Mitochondria Dysfunction To Fight Chronic Disease

MitoSense’s MOT™ technology was featured in a recent Newsmax article. The article highlights how U.S. Department of Health and Human...

Apr 29, 2025

MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases

February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...

Feb 3, 2025

MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases

Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...

Dec 2, 2024